Skip to main content
Published locations for IMpower133: Atezolizumab plus standard chemotherapy boosted survival in ES-SCLC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
IMpower133: Atezolizumab plus standard chemotherapy boosted survival in ES-SCLC
User login
Username
Password
Reset your password
/content/impower133-atezolizumab-plus-standard-chemotherapy-boosted-survival-es-sclc
/oncologypractice/article/176196/lung-cancer/impower133-atezolizumab-plus-standard-chemotherapy
/hematology-oncology/article/176196/lung-cancer/impower133-atezolizumab-plus-standard-chemotherapy